Video

Expert: MDMA-Assisted Therapy Has Potential Benefits for Women with Hypoactive Sexual Desire Disorder

Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

In part 1 of an interview with Pharmacy Times, Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

Mind Cure Health has launched The Desire Project, which is investigating the potential use of MDMA-assisted psychotherapy for the treatment of female hypoactive sexual desire disorder. In the interview, Ramsden discussed how sexual health is directly linked with mental health, how MDMA-assisted psychotherapy could be used to treat the disorder, and why the Desire Project is directly focusing on women.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Psychiatric pharmacist -- Image credit: HBS | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com